Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Pharmacology, Biochemistry, and Behavior|October 1, 1987
Recording oral activity in rats reveals a long-lasting subsensitivity to haloperidol as a function of duration of previous haloperidol treatmentR E See, W W Sant, G D EllisonPsychopharmacology|May 16, 2001
Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behaviorR E See, P J Kruzich, J W GrimmSynapse (New York, N.Y.)|October 1, 1992
Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in ratsR E See, M A Chapman, C K MeshulPsychopharmacology|January 1, 1988
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administrationR E See, E D Levin, G D EllisonDrug and Alcohol Dependence|January 5, 2000
The importance of a compound stimulus in conditioned drug-seeking behavior following one week of extinction from self-administered cocaine in ratsR E See, J W Grimm, P J Kruzich, et al.Brain Research Bulletin|September 1, 1992
Regional differences in chronic neuroleptic effects on extracellular dopamine activityR E See, M A Chapman, C E Murray, et al.Life Sciences|September 21, 1987
Neuroleptic-induced oral movements in rats: methodological issuesA D Levy, R E See, E D Levin, et al.Psychopharmacology|March 4, 2008
Relapse to cocaine seeking increases activity-regulated gene expression differentially in the prefrontal cortex of abstinent ratsM C Hearing, S W Miller, R E See, et al.Synapse (New York, N.Y.)|November 9, 2000
Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in ratsJ W Grimm, M A Chapman, D S Zahm, et al.Neuropharmacology|December 1, 1991
In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonistsR E See, B A Sorg, M A Chapman, et al.Pageof 6